(Q36684801)

15 August 2017

1 reference

title

Achieving blood pressure goals: why aren't we? (English)

1 reference

15 August 2017

William C Cushman

1

1 reference

15 August 2017

Jan Basile

series ordinal

2

1 reference

15 August 2017

language of work or name

1 reference

1 December 2006

1 reference

Journal of Clinical Hypertension

15 August 2017

published in

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

865-872

1 reference

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Characteristics of patients with uncontrolled hypertension in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Hypertension in Adults Across Age Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

Differential Control of Systolic and Diastolic Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05789.X

10.1111/J.1524-6175.2006.05789.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference